Urokinase For Injection

Get a Price/Quote

Ask A Question Send Inquiry

Price And Quantity

Payment Terms Letter of Credit (L/C), Delivery Point (DP), Days after Acceptance (DA), Cheque, Cash in Advance (CID), Cash Advance (CA)
Supply Ability 50000 Piece Per Day
Delivery Time 30-40 Days
Sample Available Yes
Sample Policy Free samples are available
Main Export Market(s) Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
Main Domestic Market All India

Urokinase For Injection

Indications :

Coronary artery thrombosis (associated with an evolving transmural myocardial infarction).
Acute pulmonary embolism.

Dosage

Coronary artery thrombosis associated with evolving transmural myocardial infarction :
Within 6 hours after the onset of symptoms as IV.
Loading Dose : 4,400 IU per kg of body wt.
Maintenance Dose : 4,400 IU/kg/hour reconstituted in 200 ml of sterile physiological saline of 6-12 hrs.
Intracoronary Administration : Infusion at a rate of 6000 I.U. /min. (Max. dose = 10,000 I.U. /Kg of body weight).
Pulmonary Embolism DVT (Deep Vein Thrombosis & Peripheral Vascular Thrombo-embolism :
Loading Dose : 4,400 IU per kg of body wt. reconstituted in 15 ml of dextrose IV over 10 min.
Maintenance Dose : 4,400 IU/kg/hour reconstituted in 200 ml of sterile physiological saline of 8-12 hrs. The total duration of the treatment usually lasts 6 to 13 days.
Anticoagulant Therapy : Following treatment with urokinase, anticoagulants (Heparin) are recommended to prevent or minimize the follow-up thrombosis.